KR20010050841A - Fibre and Fabrics with Magnetic Material - Google Patents
Fibre and Fabrics with Magnetic Material Download PDFInfo
- Publication number
- KR20010050841A KR20010050841A KR1020000058215A KR20000058215A KR20010050841A KR 20010050841 A KR20010050841 A KR 20010050841A KR 1020000058215 A KR1020000058215 A KR 1020000058215A KR 20000058215 A KR20000058215 A KR 20000058215A KR 20010050841 A KR20010050841 A KR 20010050841A
- Authority
- KR
- South Korea
- Prior art keywords
- magnetic
- magnetic material
- fine powder
- fiber
- less
- Prior art date
Links
- 239000004744 fabric Substances 0.000 title claims abstract description 21
- 239000000835 fiber Substances 0.000 title claims description 34
- 239000000696 magnetic material Substances 0.000 title claims description 32
- 230000005291 magnetic effect Effects 0.000 claims abstract description 52
- 239000002245 particle Substances 0.000 claims abstract description 24
- 239000000843 powder Substances 0.000 claims abstract description 17
- 229920002994 synthetic fiber Polymers 0.000 claims abstract description 14
- 239000012209 synthetic fiber Substances 0.000 claims abstract description 11
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 claims abstract description 7
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 claims abstract 2
- 239000010936 titanium Substances 0.000 claims abstract 2
- 229910052719 titanium Inorganic materials 0.000 claims abstract 2
- 229910000859 α-Fe Inorganic materials 0.000 claims abstract 2
- 238000000034 method Methods 0.000 claims description 19
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 claims description 14
- XEEYBQQBJWHFJM-UHFFFAOYSA-N iron Substances [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 12
- 239000006247 magnetic powder Substances 0.000 claims description 10
- 229910052742 iron Inorganic materials 0.000 claims description 5
- 239000000126 substance Substances 0.000 claims description 5
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 claims description 4
- 239000004753 textile Substances 0.000 claims description 4
- 229910001566 austenite Inorganic materials 0.000 claims description 3
- 239000010941 cobalt Substances 0.000 claims description 2
- 229910017052 cobalt Inorganic materials 0.000 claims description 2
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 claims description 2
- 238000004043 dyeing Methods 0.000 claims description 2
- LIKBJVNGSGBSGK-UHFFFAOYSA-N iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[Fe+3].[Fe+3] LIKBJVNGSGBSGK-UHFFFAOYSA-N 0.000 claims description 2
- 229910052759 nickel Inorganic materials 0.000 claims description 2
- AJCDFVKYMIUXCR-UHFFFAOYSA-N oxobarium;oxo(oxoferriooxy)iron Chemical compound [Ba]=O.O=[Fe]O[Fe]=O.O=[Fe]O[Fe]=O.O=[Fe]O[Fe]=O.O=[Fe]O[Fe]=O.O=[Fe]O[Fe]=O.O=[Fe]O[Fe]=O AJCDFVKYMIUXCR-UHFFFAOYSA-N 0.000 claims description 2
- WGLPBDUCMAPZCE-UHFFFAOYSA-N Trioxochromium Chemical compound O=[Cr](=O)=O WGLPBDUCMAPZCE-UHFFFAOYSA-N 0.000 claims 1
- 229910000423 chromium oxide Inorganic materials 0.000 claims 1
- 239000002759 woven fabric Substances 0.000 claims 1
- 210000000653 nervous system Anatomy 0.000 abstract description 7
- 210000000987 immune system Anatomy 0.000 abstract description 6
- 230000003213 activating effect Effects 0.000 abstract description 3
- 238000004519 manufacturing process Methods 0.000 description 8
- 229920000728 polyester Polymers 0.000 description 7
- 238000009987 spinning Methods 0.000 description 7
- 239000004594 Masterbatch (MB) Substances 0.000 description 5
- 229910052751 metal Inorganic materials 0.000 description 5
- 239000002184 metal Substances 0.000 description 5
- 229920001778 nylon Polymers 0.000 description 5
- 239000004677 Nylon Substances 0.000 description 4
- 239000004743 Polypropylene Substances 0.000 description 4
- -1 polypropylene Polymers 0.000 description 4
- 229920001155 polypropylene Polymers 0.000 description 4
- 229920005989 resin Polymers 0.000 description 4
- 239000011347 resin Substances 0.000 description 4
- 229920000742 Cotton Polymers 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 239000002781 deodorant agent Substances 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- OHVLMTFVQDZYHP-UHFFFAOYSA-N 1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-2-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]ethanone Chemical compound N1N=NC=2CN(CCC=21)C(CN1CCN(CC1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)=O OHVLMTFVQDZYHP-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- LDXJRKWFNNFDSA-UHFFFAOYSA-N 2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]ethanone Chemical compound C1CN(CC2=NNN=C21)CC(=O)N3CCN(CC3)C4=CN=C(N=C4)NCC5=CC(=CC=C5)OC(F)(F)F LDXJRKWFNNFDSA-UHFFFAOYSA-N 0.000 description 1
- DFGKGUXTPFWHIX-UHFFFAOYSA-N 6-[2-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]acetyl]-3H-1,3-benzoxazol-2-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)CC(=O)C1=CC2=C(NC(O2)=O)C=C1 DFGKGUXTPFWHIX-UHFFFAOYSA-N 0.000 description 1
- TVEXGJYMHHTVKP-UHFFFAOYSA-N 6-oxabicyclo[3.2.1]oct-3-en-7-one Chemical compound C1C2C(=O)OC1C=CC2 TVEXGJYMHHTVKP-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 229920002972 Acrylic fiber Polymers 0.000 description 1
- 229910001111 Fine metal Inorganic materials 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 206010052904 Musculoskeletal stiffness Diseases 0.000 description 1
- AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 208000003464 asthenopia Diseases 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229940090961 chromium dioxide Drugs 0.000 description 1
- IAQWMWUKBQPOIY-UHFFFAOYSA-N chromium(4+);oxygen(2-) Chemical compound [O-2].[O-2].[Cr+4] IAQWMWUKBQPOIY-UHFFFAOYSA-N 0.000 description 1
- AYTAKQFHWFYBMA-UHFFFAOYSA-N chromium(IV) oxide Inorganic materials O=[Cr]=O AYTAKQFHWFYBMA-UHFFFAOYSA-N 0.000 description 1
- 239000006255 coating slurry Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 238000002653 magnetic therapy Methods 0.000 description 1
- 238000002074 melt spinning Methods 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 229920005749 polyurethane resin Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
- 125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
- 230000001012 protector Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000000191 radiation effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 238000010301 surface-oxidation reaction Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 229920002803 thermoplastic polyurethane Polymers 0.000 description 1
- 230000003867 tiredness Effects 0.000 description 1
- 208000016255 tiredness Diseases 0.000 description 1
Classifications
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M11/00—Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with inorganic substances or complexes thereof; Such treatment combined with mechanical treatment, e.g. mercerising
- D06M11/32—Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with inorganic substances or complexes thereof; Such treatment combined with mechanical treatment, e.g. mercerising with oxygen, ozone, ozonides, oxides, hydroxides or percompounds; Salts derived from anions with an amphoteric element-oxygen bond
- D06M11/36—Treating fibres, threads, yarns, fabrics or fibrous goods made from such materials, with inorganic substances or complexes thereof; Such treatment combined with mechanical treatment, e.g. mercerising with oxygen, ozone, ozonides, oxides, hydroxides or percompounds; Salts derived from anions with an amphoteric element-oxygen bond with oxides, hydroxides or mixed oxides; with salts derived from anions with an amphoteric element-oxygen bond
- D06M11/49—Oxides or hydroxides of elements of Groups 8, 9,10 or 18 of the Periodic Table; Ferrates; Cobaltates; Nickelates; Ruthenates; Osmates; Rhodates; Iridates; Palladates; Platinates
-
- D—TEXTILES; PAPER
- D01—NATURAL OR MAN-MADE THREADS OR FIBRES; SPINNING
- D01F—CHEMICAL FEATURES IN THE MANUFACTURE OF ARTIFICIAL FILAMENTS, THREADS, FIBRES, BRISTLES OR RIBBONS; APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OF CARBON FILAMENTS
- D01F1/00—General methods for the manufacture of artificial filaments or the like
- D01F1/02—Addition of substances to the spinning solution or to the melt
- D01F1/10—Other agents for modifying properties
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06M—TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS
- D06M23/00—Treatment of fibres, threads, yarns, fabrics or fibrous goods made from such materials, characterised by the process
- D06M23/08—Processes in which the treating agent is applied in powder or granular form
Landscapes
- Engineering & Computer Science (AREA)
- Textile Engineering (AREA)
- Manufacturing & Machinery (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Artificial Filaments (AREA)
- Woven Fabrics (AREA)
Abstract
Description
본 발명은 자성체를 함유한 합성섬유 및 직물에 관한 것으로, 보다 상세하게로는 인체의 활성을 향상시킬 수 있는 자성체를 함유한 기능성 합성섬유 및 직물에 관한 것이다.The present invention relates to a synthetic fiber and fabric containing a magnetic material, and more particularly to a functional synthetic fiber and fabric containing a magnetic material that can improve the activity of the human body.
최근 각종 기능성 섬유가 많이 등장하고 있는데 그 중에도 건강과 관련된 원적외선 방사, 항균, 탈취, 소취 기능을 갖는 기능성 섬유들이 주류를 이루고 있다. 이 중 원적외선은 생체 세포를 활성화시킴으로써 건강을 증진시킨다는 사실이 입증됨에 따라 최근에는 원적외선 방사효과를 부여한 기능성 섬유가 각광을 받고 있다.Recently, various functional fibers have appeared, and among them, functional fibers having far-infrared radiation, antibacterial, deodorant, and deodorant functions related to health are the mainstream. Among them, as far infrared rays have been proved to promote health by activating living cells, functional fibers which have given far infrared radiation effects have been in the spotlight recently.
한편, 자석 또한 생체를 활성화시키고 인체의 신경계와 면역계를 안정화시킨다는 효과가 입증됨에 따라, 이를 이용하여 질병을 치료하고 건강을 증진시키고자 하는 여러 가지의 시도가 있었다. 그 중 대표적인 것으로는 한국 특허 제1993-1311호에 개시된 바와 같은 자기치료용 매트리스를 들 수 있다. 이 기술은 고밀도의 자기가 인체에 침투하게 되면 인체 각 부분의 혈행을 촉진하고 근육의 결림을 이완시킬 뿐만 아니라, 신경을 안정시키고 신진대사를 촉진한다는 원리를 이용한 것으로, 매트리스 내부에 N극 및 S극의 영구자석을 교대로 배열하여 여기에서 발생된 자기장이 인체에 침투할 수 있도록 한 것이다.On the other hand, as magnets have also been shown to be effective in activating the living body and stabilizing the nervous and immune systems of the human body, various attempts have been made to treat diseases and improve health using them. Representative examples thereof include magnetic therapy mattresses as disclosed in Korean Patent No. 1993-1311. This technology uses the principle that when high-density pores penetrate the human body, it not only promotes blood circulation in each part of the human body, relaxes muscle stiffness, but also stabilizes nerves and promotes metabolism. The permanent magnets of the poles are alternately arranged so that the magnetic field generated therein can penetrate the human body.
이 외에 상업화된 기술로는 디스크 환자용 허리보호대에 영구자석을 부여하여 치료효과를 향상시킨 것과, 각종 질병을 치료하기 위하여 인체의 혈에 침을 놓는 대신에 소형 영구자석을 부착시키는 기술을 들 수 있다.In addition, commercialized technologies include permanent magnets on disc patients' waist protectors to improve the therapeutic effect, and attach small permanent magnets instead of saliva to human blood to treat various diseases. .
그러나 상기 기술들은 모두 국부적인 부위의 치료효과는 있을 수 있겠으나, 발생된 자기장이 부분적으로 차이가 심하여 인체의 미세 자기장을 교란시켜 인체의 신경계 또는 면역계를 부조화 상태에 빠뜨릴 수 있다.However, all of the above techniques may have a local therapeutic effect, but the generated magnetic field is partially different so that the magnetic field of the human body may be disturbed and the nervous or immune system of the human body may be discordant.
또한, 상기 기술 중 자석요 또는 자석 매트리스의 경우는 부착된 딱딱한 영구자석으로 인하여 이를 이용하여 취침시에 안락감이 저하되는 문제점을 가지고 있다.In addition, in the case of the magnet yoyo or magnetic mattress in the above technology has a problem that the comfort is lowered at bedtime by using the hard permanent magnet attached thereto.
본 발명은 상기한 바와 같은 문제점을 해결하기 위한 것으로, 인체에 균일한 자기장을 부여함으로써 인체에 존재하는 미세 자기장이 외부의 자기파로부터 교란되는 것을 완화시켜 미세 자기장에 의해 조절되는 신경계, 면역계가 안정한 상태를 유지할 수 있도록 하는 것을 목적으로 한다.The present invention is to solve the problems as described above, by providing a uniform magnetic field to the human body to mitigate the disturbance from the external magnetic waves of the fine magnetic field present in the human body is stable by the nervous system, immune system is controlled by the fine magnetic field It aims to be able to maintain state.
본 발명의 다른 목적은 생체를 활성화시킬 수 있는 자기효과를 인체에 지속적으로 부여할 수 있도록 하는 것이다.Another object of the present invention is to be able to continuously give the human body a magnetic effect that can activate the living body.
본 발명자들은 인간이 항시 착용하는 의복의 원료가 되는 섬유 또는 직물에 자성체를 도입함으로써 상기 목적을 달성하였으며, 본 발명의 합성섬유는 입자의 평균 크기가 0.5 ㎛ 이하이고, 90% 입자크기가 1.0㎛이하이며, 최대 입자크기가 2.0 ㎛ 이하이고, 50 - 3000 Oe의 보자력을 가진 자성체 미분말 0.3 - 10 중량% 함유한 것을 특징으로 한다.The inventors of the present invention have achieved the above object by introducing a magnetic material into a fiber or a fabric which is a raw material of a garment worn by humans at all times, and the synthetic fibers of the present invention have an average particle size of 0.5 μm or less, and a 90% particle size of 1.0 μm. It is characterized in that it contains less than 0.3 ㎛ 10% by weight of the magnetic powder having a maximum particle size of 2.0 ㎛ or less, having a coercive force of 50-3000 Oe.
본 발명의 직물은 입자의 평균 크기가 0.5 ㎛ 이하이고, 90% 입자크기가 1.0㎛이하이며, 최대 입자크기가 2.0 ㎛ 이하이고, 50 - 3000 Oe의 보자력을 가진 자성체 미분말 0.3 - 10 중량%가 원단 표면에 도포된 것을 특징으로 한다The fabric of the present invention has an average particle size of 0.5 μm or less, 90% particle size of 1.0 μm or less, maximum particle size of 2.0 μm or less, and 0.3-10 wt% of magnetic fine powder having a coercivity of 50-3000 Oe. Characterized in that applied to the surface of the fabric
이하, 본 발명을 상세히 설명한다.Hereinafter, the present invention will be described in detail.
본 발명에서 사용가능한 자성체로는 산화물계의 자성 산화철(γ-Fe203)과 코발트 첨가 자성산화철, 크롬 첨가 자성 산화철, 합성 마그네타이트(Fe3O4), 이산화 크롬자성체 및 수직형 기록매체인 바륨 페라이트 등이며, 금속 분말로는 철계 미분말, 코발트계 미분말 및 니켈계 미분말 등을 사용할 수 있다. 특히 금속계 미분말을 사용할 경우 표면이 산화되기 쉬워 자성의 손실 등이 우려되므로 미리 표면에 산화막을 만들어 표면 산화가 잘 일어나지 않도록 처리해 놓은 금속 미분말을 사용하는 것이 좋다.Magnetic materials usable in the present invention include oxide-based magnetic iron oxide (γ-Fe 2 O 3 ), cobalt-added magnetic iron oxide, chromium-added magnetic iron oxide, synthetic magnetite (Fe 3 O 4 ), magnetic chromium dioxide, and vertical recording media. Barium ferrite and the like, and as the metal powder, iron-based fine powder, cobalt-based fine powder, nickel-based fine powder and the like can be used. In particular, when the metal-based fine powder is used, the surface is easily oxidized and there is a fear of magnetic loss. Therefore, it is recommended to use a fine metal powder which has been treated on the surface in advance to prevent surface oxidation.
산화물계 자성체의 보자력은 50 - 1000 0e 범위의 것을 사용할 수 있으며 금속계 자성체의 보자력은 대개 500 - 2000 0e, 특수하게는 3000 0e 까지도 사용할 수 있다. 상기 범위 미만의 경우에는 생체활성, 신경계 안정 등과 같은 자기장 침투효과가 부족하게 되며, 상기 범위를 초과할 경우에는 오히려 인체의 신경계나 면역계의 부조화를 야기할 수 있다.The coercive force of the oxide-based magnetic material can be used in the range of 50-1000 0e, and the coercive force of the metal-based magnetic material can generally be used in the range of 500-2000 0e, especially 3000 0e. If it is less than the above range, the magnetic field penetration effect such as bioactivity, nervous system stability, etc. are insufficient, and if it exceeds the above range, it may cause mismatch of the nervous or immune system of the human body.
또한 섬유에 적용되는 물질이므로 섬유 방사 공정 및 후 처리 공정 등에서의 작업성을 고려하여 입자의 크기를 엄격히 제어해야 한다. 따라서 일반 섬유용 (2데니어 이하)에 사용되는 자성체 분말을 평균크기 0.5㎛ 이하, 90% 입자크기 1.0㎛ 이하, 최대 입자크기가 2.0㎛ 이하의 것을 사용하는 것이 좋으며, 솜용 또는 가발용으로 제조하는 5데니어 이상의 섬유에는 평균크기 2㎛ 이하, 90% 입자크기가 5㎛이하, 100% 입자크기가 10㎛ 이하의 것을 사용할 수 있다.In addition, since the material is applied to the fiber, the size of the particle should be strictly controlled in consideration of the workability in the fiber spinning process and the post-treatment process. Therefore, it is recommended to use the magnetic powder used for general fibers (2 denier or less) having an average size of 0.5 μm or less, 90% particle size of 1.0 μm or less, and a maximum particle size of 2.0 μm or less. For fibers of 5 denier or more, those having an average size of 2 μm or less, 90% particle size of 5 μm or less, and 100% particle size of 10 μm or less can be used.
본 발명의 방법으로 자성체를 함유한 섬유를 만들 경우 자기 특성의 향상을 위해서는 자성체 함유량이 많을수록 우수한 결과를 나타내나 자성체 함유량이 10중량%가 넘을 때는 제조 공정상 여려움이 급격히 심해지고 경제적으로도 이점이 적어지게 되며, 0.3중량% 이하인 경우에는 기능이 불충분해지게 되므로 섬유중의 자성체 함유량을 0.3 - 10중량% 범위가 적당하다.When the fiber containing the magnetic material is made by the method of the present invention, the higher the magnetic content is, the better the results are for improving the magnetic properties. However, when the magnetic content is more than 10% by weight, the difficulty is sharply increased and the economical advantages are obtained. If the amount is less than 0.3% by weight, the function becomes insufficient, so that the magnetic content in the fiber is in the range of 0.3 to 10% by weight.
상기 언급한 자성체들을 섬유 속에 균일하게 혼합된 상태로 만들기 위해서는 폴리에스터, 나일론, 아크릴, 폴리프로필렌등 섬유로서 생산이 가능한 물질들과 함께 혼합하여 용융 방사나 중합 방사할 수도 있으며, 또는 섬유를 제조 후 표면 특성을 향상시키기 위해 섬유 표면을 우레탄 수지 등으로 코팅할 때에 우레탄 등과 함께 자성체를 혼합하여 코팅함으로써 섬유 표면에 자성체가 균일하게 혼합된 섬유를 얻을 수 있다.In order to make the above-mentioned magnetic bodies uniformly mixed in the fiber, it may be mixed with materials that can be produced as fibers such as polyester, nylon, acrylic, polypropylene, and melt spun or polymerized spun, or after the fiber is manufactured When coating the surface of the fiber with a urethane resin or the like to improve the surface properties, the magnetic material is uniformly mixed with the urethane or the like to coat the magnetic material on the fiber surface.
방사법으로 섬유를 제조할 경우 섬유용 수지와 자성체를 함께 방사할 때 크게 3가지 방법으로 구분할 수 있다. 단량체로부터 중합 반응에 의해 수지 자체를 합성할 때 미리 자성체 미분말을 첨가하여 자성체를 함유한 수지를 제조하고 보관하였다가 이를 다시 용융 방사하는 방법은 기본적으로 취급 물량이 많아야 유리한 방법이다. 이 방법으로 소량 생산시 에는 경제성을 고려해야 한다.When the fiber is produced by spinning method, the fiber resin and the magnetic material can be divided into three methods when spinning together. When synthesizing the resin itself from the monomer by the polymerization reaction, a method of preparing and storing the resin containing the magnetic material by adding the fine magnetic powder in advance, and melting and spinning it again is advantageous in that the handling quantity is large. In small quantities this way, economics must be taken into account.
이에 반해 일반수지와 자성체를 미리 고농도로 혼합한 마스터 배치 칩(Master Batch Chip)을 다시 일반 자성체를 첨가하지 않은 칩과 함께 원하는 자성체 함량이 되도록 혼합하여 용융 방사하는 마스터 배치 방법은 소량 생산에도 적합한 방법이다. 또한 아크릴 섬유 생산시에 적용되는 슬러리 방사법도 역시 소량 생산에 적합한 방법이라고 볼 수 있다.On the other hand, the master batch method in which the master batch chip in which the general resin and the magnetic substance are mixed at a high concentration in advance is melted and spun into the desired magnetic substance content together with the chip without adding the general magnetic substance. to be. In addition, the slurry spinning method applied in the production of acrylic fibers can also be seen as a suitable method for small quantities production.
이밖에 섬유의 코어와 표면을 분리하여 이중방사 함으로써 원하는 부위에만 자성체를 첨가할 수도 있다.In addition, the magnetic body may be added only to a desired portion by separating and spinning the core and the surface of the fiber.
한편, 상기와 같은 방법으로 방사한 섬유의 자기적 특성을 제어할 수 있는 방법으로는 보자력 등이 다른 자성체를 사용하는 방법과 자성체의 함량을 조절하는 방법 외에 외부에서 자기장을 걸어주어 자성체를 한 방향으로 배향시켜 주는 방법이 있다. 이 방법은 섬유가 방사되어 나올 때 섬유가 냉각되는 등의 고화과정이 완결되기 전에 자성체가 함유된 섬유의 방사출구 부위에 자기장을 걸어서 섬유내부로 자성체가 원하는 방향으로 배향되도록 함으로써 자기적인 특성을 향상시키는 것이다.On the other hand, as a method to control the magnetic properties of the fiber spun by the above method, using a magnetic material having a different coercive force, etc. and a method of controlling the content of the magnetic material, in addition to the method of applying a magnetic field from the outside to the magnetic material in one direction There is a method to orientate. This method improves magnetic properties by applying a magnetic field to the spinneret of the fiber containing the magnetic material before the solidification process, such as cooling the fiber when the fiber is spun out, to orient the magnetic material in the desired direction inside the fiber. It is to let.
직물에 자성체를 도포시키는 방법은 별도의 도포공정을 거쳐 도포할 수도 있으나, 폴리에스터, 나일론, 아크릴, 폴리프로필렌, 폴리우레탄, 면, 실크, 아세테이트 등과 같은 일반섬유로 제직한 직물 원단에 프린트 인쇄방법으로 염색원단 제조시에 염료와 함께 자성체 미분말을 혼합하여 도포처리하는 것이 바람직하다.The method of applying the magnetic material to the fabric may be applied through a separate coating process, but the method of printing on a textile fabric woven from general fibers such as polyester, nylon, acrylic, polypropylene, polyurethane, cotton, silk, acetate, etc. In order to prepare the dyeing fabric, it is preferable to mix and apply the magnetic fine powder together with the dye.
본 발명의 실시예는 아래와 같다.An embodiment of the present invention is as follows.
[제조실시예 1]Preparation Example 1
평균 입자 크기 0.45㎛이고, 90% 입자크기가 0.7㎛이며, 최대 입자크기가 2.0㎛이고, 보자력이 370-390 0e인 자성 산화철(γ-Fe203)을 25중량%가 되도록 일반 폴리에스터칩과 용융혼합하여 마스터 배치 칩을 만들고, 이를 다시 일반 폴리에스터칩과 최종 섬유중의 자성 산화철이 3중량%가 되도록 혼합하여 용융 방사하였다. 방사성은 양호하였으며, 이 때 얻어진 섬유는 1.2데니어의 갈색섬유였다.General polyester so that 25% by weight of magnetic iron oxide (γ-Fe 2 O 3 ) having an average particle size of 0.45 μm, a 90% particle size of 0.7 μm, a maximum particle size of 2.0 μm, and a coercive force of 370-390 0e The master batch chip was melt-mixed with the chip, and the resultant was melt-spun by mixing the general polyester chip and the magnetic iron oxide in the final fiber to be 3% by weight. The spinning property was good, and the obtained fiber was 1.2 denier brown fiber.
[제조실시예 2]Production Example 2
제조실시예 1에서 사용한 자성체 분말을 폴리우레탄 수지와 함께 혼합하여 코팅액을 제조한 후, 일반 폴리에스터로 만든 섬유 위에 코팅 처리하여 최종 섬유 중 2중량%의 자성체를 함유하는 우레탄 코팅 폴리에스터 섬유를 제조하였다.The magnetic powder used in Preparation Example 1 was mixed with a polyurethane resin to prepare a coating solution, and then coated on a fiber made of general polyester to prepare a urethane-coated polyester fiber containing 2 wt% of magnetic material in the final fiber. It was.
[제조실시예 3]Preparation Example 3
평균 입자 크기 0.4㎛이고, 90% 입자크기가 0.65㎛이며, 최대 입자 크기 2㎛이고, 보자력이 200 0e인 합성 마그네타이트(Fe304)를 사용하여 일반 나일론 칩과 함께 25%의 Fe304함량이 되도록 마스터 배치를 만들고 이를 다시 일반 나일론 칩과 함께 방사하여 4%의 자성체를 함유하는 1.5데니어의 나일론 섬유를 제조하였다.25% Fe 3 0 with regular nylon chips using synthetic magnetite (Fe 3 0 4 ) with an average particle size of 0.4 μm, 90% particle size of 0.65 μm, maximum particle size of 2 μm, and coercive force of 200 0e The master batch was made to have a content of 4 , and it was spun again with a normal nylon chip to prepare 1.5 denier nylon fibers containing 4% of magnetic material.
[제조실시예 4]Production Example 4
장축의 평균길이가 0.15㎛이고 장축/단축 비가 8/1이며 보자력이 1900 - 2100 Oe인 초미분 금속철 자성체를 20중량%가 되도록 일반 폴리프로필렌과 용융 혼합하여 마스터배치칩을 만들고 이를 다시 일반 폴리프로필렌과 혼합하여 용융 방사하여 금속철계 자성체가 2중량% 함유된 폴리프로필렌 섬유를 제조하였다.The masterbatch chip is made by melt-mixing ultrafine metal iron magnetic material with an average length of 0.15㎛ long axis, long axis / short axis ratio 8/1 and coercivity of 1900-2100 Oe with 20% by weight of general polypropylene. Melt spinning by mixing with propylene to prepare a polypropylene fiber containing 2% by weight of a metal iron-based magnetic material.
[제조실시예 5]Production Example 5
실시예 1의 자성체 미분말과 바인더로서 알긴산나트륨을 무게비 1:1로 혼합하여 코팅용 슬러리를 만들고 프린트 직물 제조방법으로 코팅하여 면 원단 표면에 자성체 분말이 2.5중량% 함유된 원단을 제조하였다.The magnetic powder of Example 1 was mixed with sodium alginate as a binder in a weight ratio of 1: 1 to form a coating slurry, and coated with a print fabric manufacturing method to prepare a fabric containing 2.5 wt% of magnetic powder on a cotton fabric surface.
[실시예 1-5 및 비교예]Example 1-5 and Comparative Example
제조실시예 1-4에 의하여 얻어진 원사를 직조하여 직물을 얻었으며, 이들과 제조실시예 5 에 의하여 얻어진 직물을 사용하여 남성용 잠옷을 제조하였다.The yarn obtained in Production Examples 1-4 was woven to obtain a fabric, and men's pajamas were manufactured using these and the fabric obtained in Production Example 5.
40 내지 50세의 가벼운 불면증 남자환자 60명(10명씩 6군)에게 7주일간 수면유도제의 복용을 중지시킨 다음, 상기와 같이 얻어진 잠옷을 10일간 착용시켜 증세의 호전상태를 테스트한 결과는 아래의 표1과 같았다. 비교예는 자성체를 함유하지 아니한 폴리에스테르 원사를 사용한 잠옷을 착용시킨 것이다.Sixty patients with mild insomnia (groups of 10) who were 40 to 50 years old had stopped taking the sleep inducing agent for 7 weeks, and then wore the pajamas obtained as described above for 10 days to test the improvement of symptoms. Table 1 was as follows. In the comparative example, pajamas using polyester yarns containing no magnetic material were worn.
[실시예 6]Example 6
자성 산화철의 함량이 3중량%인 5데니섬어 도의 솜용 폴리에스테르 원사를 만들고 이를 이용하여 베갯속으로 충전한 베개를 만들어 30-40세 사이의 병력이 없는 남자 40명에게 7일 동안 사용하게 한 결과는 아래의 표2와 같았다.The result is that a 5 dennisom cotton wool yarn containing 3% by weight of magnetic iron oxide was made and a pillow filled with a pillow was used to make 40 men without a history between 30 and 40 years old use it for 7 days. It is shown in Table 2 below.
이상의 실시예를 통하여 알 수 있는 바와 같이, 본 발명을 통하여 섬유 또는 직물에 자성체를 부여할 수 있으며, 이를 통하여 인체에 균일한 자기장을 부여함으로써 인체에 존재하는 미세 자기장이 외부의 자기파로부터 교란되는 것을 완화시켜 미세 자기장에 의해 조절되는 신경계, 면역계가 안정한 상태를 유지할 수 있도록 한다. 또한, 섬유제품 자체에 자성체를 부여하여 지속적으로 인체에 자기침투 효과가 발휘되도록 한다.As can be seen through the above embodiment, it is possible to impart a magnetic material to the fiber or fabric through the present invention, through which a magnetic field uniform to the human body is disturbed from the external magnetic waves by the magnetic field present in the human body By mitigating this, the nervous system and immune system controlled by the micro magnetic field can maintain a stable state. In addition, the magnetic product is given to the textile product itself to continuously exert a magnetic penetrating effect on the human body.
Claims (7)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1019990042694 | 1999-10-04 | ||
| KR19990042694 | 1999-10-04 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20010050841A true KR20010050841A (en) | 2001-06-25 |
Family
ID=19613927
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020000058215A KR20010050841A (en) | 1999-10-04 | 2000-10-04 | Fibre and Fabrics with Magnetic Material |
Country Status (3)
| Country | Link |
|---|---|
| KR (1) | KR20010050841A (en) |
| AU (1) | AU7965200A (en) |
| WO (1) | WO2001025514A1 (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20150004020U (en) * | 2014-04-24 | 2015-11-03 | 김건호 | fabric for absorb and neutralizing of electromagnetic wave |
| CN108411405A (en) * | 2018-04-03 | 2018-08-17 | 青岛大学 | A kind of Fe2O3/TiO2Composite nano fiber and preparation method thereof |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200427881A (en) | 2003-05-19 | 2004-12-16 | Toray Industries | Fiber excellent in magnetic field response and conductivity and product made therefrom |
| DE102008003847A1 (en) * | 2008-01-10 | 2009-07-16 | Robert Bosch Gmbh | Process for the production of fibers, fibers and their use |
| US20170037568A1 (en) | 2015-08-05 | 2017-02-09 | Milliken & Company | Installation of Multi-Component Floor Mat |
| PL3500623T3 (en) * | 2016-08-22 | 2021-11-15 | S-Techs Gmbh | Production method for a polymer material comprising at least one or more different doping elements |
| US20180055266A1 (en) | 2016-08-24 | 2018-03-01 | Milliken & Company | Floor Mat with Hidden Base Component |
| CA3059778A1 (en) * | 2017-03-23 | 2018-09-27 | Boston Materials, Inc. | Fiber-reinforced composites, methods therefor, and articles comprising the same |
| JP2022512188A (en) | 2018-12-10 | 2022-02-02 | ボストン・マテリアルズ・インコーポレイテッド | Systems and methods for carbon fiber alignment and fiber reinforced composites |
| US11479656B2 (en) | 2019-07-10 | 2022-10-25 | Boston Materials, Inc. | Systems and methods for forming short-fiber films, composites comprising thermosets, and other composites |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS57167416A (en) * | 1980-11-19 | 1982-10-15 | Kanebo Synthetic Fibers Ltd | Magnetic fiber |
| KR970001664A (en) * | 1995-06-19 | 1997-01-24 | 구자홍 | Hand washing stroke control method and device of washing machine |
| KR100216968B1 (en) * | 1997-07-23 | 1999-10-01 | 김윤 | Magnetism polyester fiber manufacture method |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS59112018A (en) * | 1982-12-15 | 1984-06-28 | Teijin Ltd | Magnetizable fiber, their bundle, production, magnetic fiber and magnetic fiber structure |
| JPH0214017A (en) * | 1988-06-27 | 1990-01-18 | Naoki Sato | Magnetic fiber, production of magnetic fiber and production of magnetic woven cloth |
| US5183515A (en) * | 1989-11-07 | 1993-02-02 | Unitika Ltd. | Fibrous anisotropic permanent magnet and production process thereof |
| JP3362493B2 (en) * | 1993-12-28 | 2003-01-07 | 日本エクスラン工業株式会社 | Magnetic fiber and method for producing the same |
-
2000
- 2000-10-04 WO PCT/KR2000/001108 patent/WO2001025514A1/en active Application Filing
- 2000-10-04 AU AU79652/00A patent/AU7965200A/en not_active Abandoned
- 2000-10-04 KR KR1020000058215A patent/KR20010050841A/en active Search and Examination
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS57167416A (en) * | 1980-11-19 | 1982-10-15 | Kanebo Synthetic Fibers Ltd | Magnetic fiber |
| KR970001664A (en) * | 1995-06-19 | 1997-01-24 | 구자홍 | Hand washing stroke control method and device of washing machine |
| KR100216968B1 (en) * | 1997-07-23 | 1999-10-01 | 김윤 | Magnetism polyester fiber manufacture method |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20150004020U (en) * | 2014-04-24 | 2015-11-03 | 김건호 | fabric for absorb and neutralizing of electromagnetic wave |
| CN108411405A (en) * | 2018-04-03 | 2018-08-17 | 青岛大学 | A kind of Fe2O3/TiO2Composite nano fiber and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2001025514A1 (en) | 2001-04-12 |
| AU7965200A (en) | 2001-05-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR20010050841A (en) | Fibre and Fabrics with Magnetic Material | |
| CN1141438C (en) | Health-care far infrared and negative oxygen ion fabric and its preparing process | |
| CN108606373A (en) | Biological intelligence health clothing | |
| CN105648575A (en) | Copper-modified fibers and blended fabric produced by same | |
| EP0318520A1 (en) | Magnetisable man-made fibres | |
| CN104605684B (en) | A kind of pocket magnetic therapy bed | |
| US20050076435A1 (en) | Health bedding | |
| KR20010018325A (en) | Synthetic Fibre with the Properties of Antibiotics, Deorderising and Far-infrared Ray Emmision | |
| KR20010038677A (en) | Fibre with Magnetic Property | |
| CN108385190A (en) | A kind of nylon fibre and preparation method thereof with magnetic-therapy healthcare function | |
| CN108060493A (en) | Radioresistance back cushion and preparation method thereof | |
| JP2009035850A (en) | Magnetizable filaments and fabrics | |
| KR101829031B1 (en) | Fiber with antibacterial, bactericidal, far-infrared radiation emissive and anion emissive | |
| KR20030040587A (en) | Method for producing functional polyester fiber | |
| CN201451378U (en) | Health-care underwear | |
| CN212451812U (en) | Novel composite nylon fancy yarn | |
| KR102080430B1 (en) | Sheath-core type composite yarn containing Inorganic antibiotics and manufacturing method thereof | |
| KR100780320B1 (en) | Method of proparing of polyester resin containing functional mineral material | |
| CN107142553A (en) | The method for preparing magnetic fibre | |
| KR20010046017A (en) | Fibre with Hard Ferrite Fine Powder | |
| CN113047036A (en) | Jade-zinc ice health-care fiber and preparation method thereof | |
| KR950000376B1 (en) | Polypropylene filament having herbs for health and producing method thereof | |
| CN205800402U (en) | A kind of terylene warp knitted blanket of moisture-proof, antibiotic | |
| CN111118666A (en) | Germanium-containing decompression anti-fatigue fiber and preparation method thereof | |
| KR200401096Y1 (en) | Multi role fale hair |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A201 | Request for examination | ||
| AMND | Amendment | ||
| E902 | Notification of reason for refusal | ||
| AMND | Amendment | ||
| E902 | Notification of reason for refusal | ||
| E601 | Decision to refuse application | ||
| AMND | Amendment | ||
| J201 | Request for trial against refusal decision | ||
| B601 | Maintenance of original decision after re-examination before a trial | ||
| J301 | Trial decision |
Free format text: TRIAL DECISION FOR APPEAL AGAINST DECISION TO DECLINE REFUSAL REQUESTED 20031118 Effective date: 20050728 |